Sterne Agee Initiates Charles River Laboratories Coverage: Buy, $43 PT

Symbols: CRL
Share

Sterne Agee initiated coverage on Charles River Laboratories (NYSE: CRL) with a Buy rating and $43 price target in a research report published today.


 
 
< Previous
Singular Research Reiterates HSN Buy, Raises PT
Next >
Sterne Agee Initiates Covance Coverage: Buy, $59 PT
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust